Skip to main content
    C

    CONMED Corporation (CNMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $47.11
    +2.18 (+4.85%)

    Market Cap: $1.35B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    92%(36/39)
    Avg Surprise
    +15.68%
    Streak
    10 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.00
    Range$0.99 - $1.02
    7 analysts
    EPS Revisions
    1
    0
    7d
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$1.02-1.5%
    60d ago$1.000.0%
    30d ago$1.000.0%
    7d ago$1.000.0%
    Current$1.00
    Revenue Consensus
    $336M
    Range$335M - $337M
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.61
    Range$1.59 - $1.61
    7 analysts
    Revenue Consensus
    $382M
    Range$380M - $386M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.61---
    Sep 26EST
    		-$1.00---
    Jun 26
    Reported Jul 29
    		$1.38$1.10+25.45%Beat+20.0%
    Mar 26
    Reported Apr 29
    		$0.89$0.82+8.54%Beat-6.3%
    Dec 25
    Reported Jan 28
    		$1.43$1.32+8.33%Beat+6.7%
    Sep 25
    Reported Nov 5
    		$1.08$1.05+2.86%Beat+2.9%
    Jun 25
    Reported Jul 30
    		$1.15$1.12+2.68%Beat+17.3%
    Mar 25
    Reported Apr 30
    		$0.95$0.81+17.28%Beat+20.3%
    Dec 24
    Reported Feb 5
    		$1.34$1.20+11.67%Beat+26.4%
    Sep 24
    Reported Oct 30
    		$1.05$1.00+5.00%Beat+16.7%
    Jun 24
    Reported Jul 31
    		$0.98$0.91+7.69%Beat+18.1%
    Mar 24
    Reported Apr 24
    		$0.79$0.74+6.76%Beat+19.7%
    Dec 23
    Reported Jan 31
    		$1.06$1.11-4.50%Miss+152.4%
    Sep 23
    Reported Oct 25
    		$0.90$0.83+8.43%Beat+16.9%
    Jun 23
    Reported Jul 26
    		$0.83$0.79+5.06%Beat+9.2%
    Mar 23
    Reported Apr 26
    		$0.66$0.60+10.00%Beat-5.7%
    Dec 22
    Reported Feb 2
    		$0.42N/A-53.33%Miss-60.7%
    Sep 22
    Reported Oct 26
    		$0.77$0.75+2.67%Beat-3.8%
    Jun 22
    Reported Jul 27
    		$0.76$0.75+1.33%Beat+7.0%
    Mar 22
    Reported May 4
    		$0.70$0.62+12.90%Beat+11.1%
    Dec 21
    Reported Jan 26
    		$1.07$1.03+3.88%Beat+27.4%
    Sep 21
    Reported Oct 27
    		$0.80$0.75+6.67%Beat-9.1%
    Jun 21
    Reported Jul 28
    		$0.71$0.62+14.52%Beat+1114.3%
    Mar 21
    Reported Apr 28
    		$0.63$0.44+43.18%Beat+23.5%
    Dec 20
    Reported Jan 27
    		$0.84$0.77+9.09%Beat-6.7%
    Sep 20
    Reported Oct 28
    		$0.88$0.23+282.61%Beat+41.9%
    Jun 20
    Reported Jul 29
    		$-0.07N/A+92.63%Beat-112.5%
    Mar 20
    Reported Apr 29
    		$0.51$0.44+15.91%Beat-10.5%
    Dec 19
    Reported Jan 29
    		$0.90$0.89+1.12%Beat+23.3%
    Sep 19
    Reported Oct 30
    		$0.62$0.56+10.71%Beat+34.8%
    Jun 19
    Reported Jul 31
    		$0.56$0.53+5.66%Beat+21.7%
    Mar 19
    Reported Apr 24
    		$0.57$0.54+5.56%Beat+7.5%
    Dec 18
    Reported Jan 22
    		$0.73$0.73+0.00%Beat+5.8%
    Sep 18
    Reported Nov 1
    		$0.46$0.45+2.22%Beat+9.5%
    Jun 18
    Reported Aug 1
    		$0.46$0.45+2.22%Beat+12.2%
    Mar 18
    Reported Apr 25
    		$0.53$0.43+23.26%Beat+39.5%
    Dec 17
    Reported Jan 31
    		$0.69$0.65+6.15%Beat+27.8%
    Sep 17
    Reported Nov 2
    		$0.42$0.41+2.44%Beat-
    Jun 17
    Reported Jul 26
    		$0.41$0.41+0.00%Beat-
    Mar 17
    Reported Apr 26
    		$0.38$0.35+8.57%Beat-
    Dec 16
    Reported Feb 1
    		$0.54$0.56-3.57%Miss-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    FrequencyQuarterly
    Pay MonthsOct

    Growth

    3Y CAGR-9.14%
    5Y CAGR-5.59%

    Key Metrics

    Valuation
    P/E Ratio9.86EV/EBITDA11.43x
    Price/FCF10.53xFCF Yield9.49%
    Profitability
    Profit Margin4.12%Operating Margin14.60%
    ROE5.53%ROIC4.09%
    Financial Health
    Debt/Equity0.80xInterest Coverage3.78x
    Current Ratio1.48xQuick Ratio0.69x
    Trading Statistics
    Beta0.94Avg Volume390.94K
    52-Week High$53.6652-Week Low$31.44

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$45.48
    SMA 20$45.64
    SMA 50$47.71
    SMA 200$41.14
    EMA 10$45.65
    EMA 20$45.90
    EMA 50$45.87
    EMA 200$43.42

    MACD

    Line: -0.39Signal: -0.52Hist: 0.13

    ADX

    ADX: 14.3+DI: 21.1-DI: 13.8

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down76.0
    PSAR$43.97

    Bollinger Bands

    Upper Band$47.41
    Lower Band$43.87
    %B Position777%(Upper)
    Band Width0.91

    RSI (14-Day)

    Neutral
    54.9

    Momentum Oscillators

    Stoch %K44.2
    Stoch %D33.8
    Williams %R-26.6
    ROC (10d)2.6%
    Momentum1.18
    CCI (20d)134.5
    MFI (14d)70.6

    Volatility Measures

    ATR (14d)$1.70(3.6%)
    StdDev (20d)0.89
    Hist Vol37.2%(Moderate)

    Volume Flow

    VWAP$46.84
    OBV6.4M
    AD Line-16.6M
    CMF (20d)-0.017

    Volume Metrics

    Avg Vol (20d)399.8K
    Vol Ratio1.0x
    VWMA (20d)$45.55

    Pivot Points

    R3$48.23
    R2$47.41
    R1$46.17
    Pivot Point$45.35
    S1$44.11
    S2$43.29
    S3$42.05

    Advanced Oscillators

    TSI-8.11
    Ultimate Osc54.3
    KST-49.55

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$343.49M$317.05M$373.20M$337.93M$342.35M$321.26M$345.94M$316.70M$332.10M$312.27M$327.05M$304.58M
    Cost of Revenue$146.03M$133.60M$154.91M$171.81M$154.03M$143.50M$147.60M$137.71M$148.37M$140.31M$144.87M$136.52M
    Gross Profit$197.46M$183.45M$218.28M$166.12M$188.32M$177.75M$198.34M$179.00M$183.73M$171.97M$182.18M$168.06M
    Operating Expenses$161.05M$158.03M$181.66M$154.24M$150.16M$161.79M$145.84M$113.29M$136.62M$136.95M$131.99M$137.76M
    R&D$15.50M$16.33M$14.90M$13.90M$14.14M$12.95M$13.18M$13.56M$14.10M$13.59M$14.03M$12.46M
    SG&A$145.55M$141.70M$166.76M$140.34M$136.02M$148.85M$132.67M$99.73M$122.52M$123.36M$117.96M$125.30M
    Operating Income$36.41M$25.41M$36.62M$11.88M$38.16M$15.96M$52.50M$65.71M$47.11M$35.01M$50.19M$30.30M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$7.88M$7.06M$7.37M$7.61M$7.82M$8.29M$8.86M$9.25M$9.59M$9.59M$9.50M$10.02M
    Income Before Tax$31.35M$18.36M$29.25M$4.27M$29.92M$7.67M$43.64M$56.45M$37.51M$25.42M$40.68M$20.28M
    Income Tax Expense$8.28M$4.53M$12.51M$1.41M$8.50M$1.64M$9.89M$7.47M$7.54M$5.71M$7.61M$4.44M
    Net Income$23.07M$13.83M$16.74M$2.86M$21.42M$6.04M$33.75M$48.98M$29.98M$19.71M$33.07M$15.84M
    EBITDA$59.33M$45.53M$57.01M$31.76M$57.70M$35.65M$71.95M$85.12M$66.35M$54.46M$69.69M$49.72M
    EBIT$39.23M$25.41M$36.62M$11.88M$37.74M$15.96M$52.50M$65.71M$47.11M$35.01M$50.19M$30.30M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CNMD

    Government Contracts

    Gov Obligations (TTM)
    $74235
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    5
    New Awards (TTM)
    1
    Avg Remaining Term
    6.9 mo

    Top agency: Department of Veterans Affairs at 98.7% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24926N0650Department of Veterans AffairsDepartment of Veterans Affairs$9890Aug 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    CONMED Corporation (CNMD) Stock forecasts

    Argus has lowered its target price for CONMED Corporation (CNMD) to $47.00. CONMED, a medical equipment company specializing in sports medicine and general surgeries...

    Yahoo Finance Singapore•10/11/26•Somewhat-Bullish

    Understanding Momentum Shifts in (CNMD)

    This article provides an AI-driven analysis of Conmed Corp. (NASDAQ: CNMD), highlighting a weak near-term sentiment but an exceptional risk-reward setup targeting a 15.6% gain. It outlines three distinct institutional...

    Stock Traders Daily•10/9/26•Somewhat-Bearish

    CONMED Corporation (NYSE:CNMD) Stock Has Average Price Target of $41.40

    CONMED Corporation (NYSE:CNMD) has received an average "Reduce" rating from eight research firms, with an average 1-year target price of $41.40...

    MarketBeat•10/9/26•Somewhat-Bullish

    Conmed Corp (EC8.SG) Analyst insights, Price targets and Recommendations

    This article provides analyst insights, price targets, and recommendations for Conmed Corp (EC8.SG). It lists recent upgrades and downgrades from various financial institutions, including Piper Sandler, Wells Fargo...

    Yahoo Finance UK•10/8/26•Neutral

    Conmed Corp (EC8.SG) Analyst Insights, Price Targets & Recommendations

    This article provides an overview of recent analyst ratings and recommendations for Conmed Corp (EC8.SG). It lists several upgrades, downgrades, and maintained ratings from various financial institutions...

    Yahoo! Finance Canada•10/6/26•Neutral

    CNMD Valuation and Fair Value

    P/E
    9.9x
    Forward P/E
    27.2x
    EV/EBITDA
    11.4x
    P/FCF
    10.5x
    PEG
    1.8x
    P/B
    1.4x
    See GNG's fair value

    CNMD Profitability: Margins, ROIC and FCF

    Gross margin
    55.8%
    Operating margin
    14.6%
    Net margin
    4.1%
    ROIC
    4.1%
    ROE
    5.5%
    FCF margin
    9.8%
    FCF yield
    9.5%

    CNMD Competitors

    CompanyTicker
    Rapport Therapeutics, Inc. Common StockRAPP
    Omeros CorporationOMER
    Kalvista Pharmaceuticals IncKALV
    Mind Medicine IncMNMD
    Nutex Health IncNUTX
    Alpha Tau Medical LtdDRTS
    AMN Healthcare Services IncAMN
    Tyra Biosciences IncTYRA

    Sector: Healthcare

    CNMD Analyst Ratings

    Consensus
    Hold
    Analysts
    7
    Strong Buy
    0
    Buy
    0
    Hold
    6
    Sell
    0
    Strong Sell
    1

    CNMD Bull Case vs Bear Case

    Bull case

    • CNMD beat EPS estimates in 100.0% of its last 8 reported quarters.

    CNMD Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    10.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.00
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    CNMD Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%
    3Y DPS growth
    -9.1%
    5Y DPS growth
    -5.6%
    Pay months
    Oct

    Frequently Asked Questions About CNMD

    Does CNMD pay dividends?

    CONMED Corporation (CNMD) has a dividend payment track record. See the CNMD dividend history page for its current payment status, TTM yield, and recorded payments.

    What is CNMD's P/E ratio?

    CONMED Corporation has a price-to-earnings (P/E) ratio of 9.86.

    What is CNMD's market cap?

    CONMED Corporation (CNMD) has a market capitalization of $1.35B with a current stock price of $47.11.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In